Vivani Medical Insider Buy & $4.5M Raise Signal Growth: What It Means for Investors
Vivani Medical’s insider buy‑back and $4.5 M equity raise show management’s confidence in its implant pipeline, but investors must watch capital use, clinical milestones and reimbursement outcomes for true upside.
4 minutes to read